The options have an exercise price of
About
Contact:
E: mcarrasco@akebia.com
(C) 2021 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.485 USD | +8.39% | +11.74% | +18.95% |
23/04 | Averoa Seeks EU Approval for Chronic Kidney Disease Drug | MT |
16/04 | Akebia Therapeutics, Inc. and STA Pharmaceutical Hong Kong Limited Enters into Second Amendment to the Supply Agreement | CI |
The options have an exercise price of
About
Contact:
E: mcarrasco@akebia.com
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+18.95% | 287M | |
+8.84% | 105B | |
-1.16% | 104B | |
+5.79% | 22.94B | |
-12.44% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.18% | 16.96B | |
+7.86% | 14.16B | |
+38.20% | 12.63B |